Not applicableUnknownNCT03815864What this trial is testingAntibodies and Liver RetransplantationWho this might be right forLiver Transplant FailureAntibody-mediated Rejection London Health Sciences Centre 200
Testing effectiveness (Phase 2)Study completedNCT00005940What this trial is testingRadiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First RemissionWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+4 more Fred Hutchinson Cancer Center 18
Not applicableStudy completedNCT03423901What this trial is testingImpact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney TransplantationWho this might be right forKidney Transplant University Hospital, Toulouse 58
Not applicableEnded earlyNCT02115503What this trial is testingA Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft RecipientsWho this might be right forRenal Transplant Recipients With Anti-HLA Antibodies Databean 52
Not applicableUnknownNCT05282875What this trial is testingAnti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to DialysisWho this might be right forKidney TransplantationImmunosuppressive AgentsHLA Sensitization+1 more Central Hospital, Nancy, France 430
Testing effectiveness (Phase 2)Study completedNCT03380377What this trial is testingClazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney TransplantWho this might be right forAntibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more Stanley Jordan, MD 10
Testing effectiveness (Phase 2)Ended earlyNCT00090194What this trial is testingImproving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%Who this might be right forKidney Failure, Chronic National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableUnknownNCT06013358What this trial is testingDdcfDNA in Kidney Transplant RecipientsWho this might be right forKidney Transplant Rejection Seoul National University Hospital 200
Not applicableStudy completedNCT03438058What this trial is testingComplement-activating Anti-human Leucocyte Antigen Donor Specific Antibodies in Solid Organ TransplantationWho this might be right forOrgan Transplant Recipients Paris Translational Research Center for Organ Transplantation 7,547
Testing effectiveness (Phase 2)Looking for participantsNCT06380816What this trial is testingA Phase I/II Trial of UCB4594 in Participants With Advanced CancerWho this might be right forAdvanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more Cancer Research UK 167
Not applicableUnknownNCT03861962What this trial is testingRe-evaluation of Donor-specific Anti-HLA Alloantibodies Immunoassay After Organ Transplantation, From Antigen Level to Epitope LevelWho this might be right forOrgan Transplantation Assistance Publique - Hôpitaux de Paris 20,000
Testing effectiveness (Phase 2)Study completedNCT02738918What this trial is testingBelatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.Who this might be right forRenal TransplantAcute Antibody Mediated RejectionMild Immunologic Risk Factor Assistance Publique - Hôpitaux de Paris 51
Not applicableStudy completedNCT07200583What this trial is testingProtein A Immunoadsorption in Highly Sensitized Haplo-HSCT PatientsWho this might be right forHematologic MalignanciesHematologic DisordersAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)+1 more Ting YANG 50
Testing effectiveness (Phase 2)Study completedNCT00307125What this trial is testingRituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA AlloantibodiesWho this might be right forKidney TransplantKidney Transplant RecipientGraft Function/Survival+1 more National Institute of Allergy and Infectious Diseases (NIAID) 757
Not applicableActive Not RecruitingNCT04277377What this trial is testingNanoparticle for DSA RemovalWho this might be right forKidney FailurePresence of Donor Specific Antibodies University of Zurich 100
Early research (Phase 1)Not Yet RecruitingNCT04579523What this trial is testing²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple MyelomaWho this might be right forMultiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827979What this trial is testingDaratumumab and Belatacept for DesensitizationWho this might be right forHighly Sensitized Prospective Kidney Transplant Recipients National Institute of Allergy and Infectious Diseases (NIAID) 19
Not applicableUnknownNCT03714113What this trial is testingDonor-specific Anti-HLA Antibodies Monitoring in Kidney Transplant RecipientsWho this might be right forKidney Transplant Rejection Medical University of Warsaw 100
Testing effectiveness (Phase 2)Study completedNCT00027560What this trial is testingMelphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more Memorial Sloan Kettering Cancer Center 51
Post-approval studies (Phase 4)Study completedNCT02284464What this trial is testingSteroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant PatientsWho this might be right forOther Complication of Kidney TransplantRenal Transplant Rejection Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 230